NLRP3 and periodontitis: The compounds inhibiting leukotoxicity, the NLRP3 inflammasome or cell-to-cell communication, are well-known in the literature and could be explored regarding their application in the treatment of A. actinomycetemcomitans-mediated periodontitis.